Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 60 2011 072 434.7 |
| 96 | EP file number | EAKZ | 19 15 4482.4 |
| 97 | EP publication number | EPN | 3502138 |
| 54 | Designation/title | TI | STILLE FC-VARIANTEN VON ANTI-CD40-ANTIKÖRPERN |
| 51 | IPC main class | ICM
(ICMV) | C07K 16/28 (2006.01) |
| 22 | DE application date | DAT | Nov 14, 2011 |
| 96 | EP application date | EAT | Nov 14, 2011 |
| 43 | Date of first publication | OT | Jun 26, 2019 |
| Date of publication of grant | PET | Jan 19, 2022 |
| 71/73 | Applicant/owner | INH | Novartis AG, Basel, CH |
| 72 | Inventor | IN | Heusser, Christoph, 4056 Basel, CH; Rush, James, 4056 Basel, CH; Vincent, Karen, 4056 Basel, CH |
| Address for service | | Novartis AG, 4056 BASEL, CH |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
41356710 P
Nov 15, 2010
|
| Due date | FT
FG | Nov 30, 2025
Annual fee for the 15th year
Patent fees |
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003502138A1
Searchable text:
EP000003502138A1
Original document:
EP000003502138B1
Searchable text:
EP000003502138B1 |
| 43 | Date of first publication | EVT | Jun 26, 2019 |
| Date of the first transfer into DPMAregister | EREGT | Jun 26, 2019 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 30, 2024
(Show all update days)(Hide all update days)- Oct 30, 2024
- Oct 17, 2024
- St.36: changed (technical change)
- Oct 21, 2023; Jan 5, 2023; Dec 1, 2022; Jul 7, 2022; Feb 3, 2022; Jan 7, 2022; Dec 30, 2021; Aug 9, 2019
- Historical data not available for this/these date(s)
- Jun 26, 2019
- Date of the first transfer into DPMAregister
|
